Wuhan Biofriend Technology Co.,Ltd

Top Grade Biotechnology Manufacturer In China

Quality Product Safe Delivery Professional Service

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsAnti Estrogen Steroids

Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer

Good quality Injectable Anabolic Steroids for sales
Good quality Injectable Anabolic Steroids for sales
Everything is perfect!The quality,prices and shipping!I will buy from you every month.

—— Carlos

The package is complete when i have it!Everything are perfect!Thank you Corleone and i will be keeping ordering!!

—— Blaker

I'm Online Chat Now

Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer

China Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer supplier
Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer supplier Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer supplier

Large Image :  Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer

Product Details:

Place of Origin: Wuhan
Brand Name: Biofriend
Certification: SGS,ISO9001,UKAS,GMP
Model Number: 82640-04-8

Payment & Shipping Terms:

Minimum Order Quantity: 10g
Price: Negotiable
Packaging Details: Discreet ways of packing for customs guaranteed
Delivery Time: Within 24 hours after payment
Payment Terms: T/T, Western Union, MoneyGram,Bitcoin,Paypal
Supply Ability: 2000kg Per Month
Contact Now
Detailed Product Description
MF: C28H28ClNO4S MW: 510.05
Purity: 99.5% Appearance: White Powder
Grade: Pharmaceutical Grade Packing:: Aluminum Foil Bag

Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer

 

CAS 82640-04-8 Raloxifene hydrochloride
 
Alias: Raloxifene hydrochloride,Raloxifene HCl
CAS Registry Number: 82640-04-8
Assay: 99%
Molecular Formula: C28H28ClNO4S
Molecular weight: 510.05
Appearance: white crystalline powder
Grade:Pharmaceutical Grade
 
Anti Estrogen Powder Evista Raloxifene Hydrochloride for Anti Cancer
Use in Cancer
 
Raloxifene hydrochloride is approved to prevent:
 
Breast cancer. It is used to decrease the chance of invasive breast cancer in postmenopausal women who have a high risk for developing the disease or who have osteoporosis.
 
 
Introduction
 
The role of raloxifene in the prevention and treatment of breast cancer is currently under investigation. There is also a similar mechanism of action of drugs, tamoxifen (tamoxifen), for the treatment of breast cancer has been a long time. It is hoped that Raloxifene will be as effective as tamoxifen with less adverse effects.
 
 
Raloxifene (marketed as Evista) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
 
This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.
 
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate.
 
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.
 
Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.

Contact Details
Wuhan Biofriend Technology Co.,Ltd

Contact Person: Ian

Send your inquiry directly to us (0 / 3000)